ENTITY

Genmab A/S (GEN DC)

6
Analysis
Health CareDenmark
Genmab A/S operates as a biotechnology company. The Company creates and develops human antibody products for the treatment of life threatening and debilitating diseases. Genmab focuses on products to treat cancer, rheumatoid arthritis and other inflammatory conditions, and psoriasis. The Company develops new products through partnerships. Genmab operates in Europe and the United States.
more
Exchange Announcement10 Nov 2022 01:00
Exchange Announcement10 Aug 2022 08:00
Exchange Announcement11 May 2022 08:00
Exchange Announcement16 Feb 2022 08:00
Exchange Announcement10 Nov 2021 08:00
x